BACKGROUND: Polymerized-type I collagen (polymerized-collagen) is a down-regulator of inflammation and a tissue regenerator biodrug. The aim of this study was to evaluate its effect in co-cultures of cartilage and synovial tissue from patients with knee osteoarthritis (OA). MATERIALS AND METHODS: Cartilage and synovial tissue from five patients with OA were co-cultured for 7 days in the presence or absence of 1% polymerized-collagen. To determine proteoglycans content, tissues were stained with alcian blue technique. Pro- and anti-inflammatory cytokines [interleukin (IL)-1beta, IL-8, IL-10, IL-12, tumour necrosis factor (TNF)-alpha, and interferon (IFN)-gamma] and tissue inhibitor of metalloproteinase (TIMP)-1 were measured in supernatants by ELISA and results were normalized by total protein concentration. Cartilage oligomeric matrix protein (COMP), type II collagen, TNF-alpha, IL-10 and Ki-67 expression were determined by immunohistochemistry. RESULTS: Polymerized-type I collagen induced an increase of 3- to 6fold cell proliferation (Ki-67), proteoglycans content, and COMP and type II collagen expression, whereas it inhibited IL-1beta and TNF-alpha production. IL-10 levels were up-regulated in treated vs. untreated cultures. No differences were found on IL-8 or TIMP-1 levels in supernatants from polymerized-collagen-treated co-cultures when compared with untreated cultures. IL-12 and IFN-gamma were undetectable. CONCLUSION: The addition of polymerized-type I collagen to cartilage and synovial tissue co-cultures induced up-regulation of chondrocytes proliferation and cartilage extracellular matrix proteins production (COMP, type II collagen and proteoglycans) as well as an anti-inflammatory cytokine (IL-10) and the down-modulation of pro-inflammatory cytokines (IL-1beta and TNF-alpha). It is possible that this mechanism might contribute to induce tissue regeneration and down-regulation of inflammation in OA.
BACKGROUND: Polymerized-type I collagen (polymerized-collagen) is a down-regulator of inflammation and a tissue regenerator biodrug. The aim of this study was to evaluate its effect in co-cultures of cartilage and synovial tissue from patients with knee osteoarthritis (OA). MATERIALS AND METHODS:Cartilage and synovial tissue from five patients with OA were co-cultured for 7 days in the presence or absence of 1% polymerized-collagen. To determine proteoglycans content, tissues were stained with alcian blue technique. Pro- and anti-inflammatory cytokines [interleukin (IL)-1beta, IL-8, IL-10, IL-12, tumour necrosis factor (TNF)-alpha, and interferon (IFN)-gamma] and tissue inhibitor of metalloproteinase (TIMP)-1 were measured in supernatants by ELISA and results were normalized by total protein concentration. Cartilage oligomeric matrix protein (COMP), type II collagen, TNF-alpha, IL-10 and Ki-67 expression were determined by immunohistochemistry. RESULTS: Polymerized-type I collagen induced an increase of 3- to 6fold cell proliferation (Ki-67), proteoglycans content, and COMP and type II collagen expression, whereas it inhibited IL-1beta and TNF-alpha production. IL-10 levels were up-regulated in treated vs. untreated cultures. No differences were found on IL-8 or TIMP-1 levels in supernatants from polymerized-collagen-treated co-cultures when compared with untreated cultures. IL-12 and IFN-gamma were undetectable. CONCLUSION: The addition of polymerized-type I collagen to cartilage and synovial tissue co-cultures induced up-regulation of chondrocytes proliferation and cartilage extracellular matrix proteins production (COMP, type II collagen and proteoglycans) as well as an anti-inflammatory cytokine (IL-10) and the down-modulation of pro-inflammatory cytokines (IL-1beta and TNF-alpha). It is possible that this mechanism might contribute to induce tissue regeneration and down-regulation of inflammation in OA.
Authors: Adrián Borja-Flores; Salvador I Macías-Hernández; Gabriela Hernández-Molina; Andric Perez-Ortiz; Eloy Reyes-Martínez; José Belzazar-Castillo de la Torre; Laura Ávila-Jiménez; María Cristina Vázquez-Bello; Marco Antonio León-Mazón; Janette Furuzawa-Carballeda; Gonzalo Torres-Villalobos; Fernanda Romero-Hernández; Cidronio Albavera-Hernández; Jesús Pérez-Correa; Hilda A Castro-Rocha Journal: Adv Orthop Date: 2020-07-22
Authors: David J Hunter; Marilyn C Pike; Beth L Jonas; Eugene Kissin; Julie Krop; Tim McAlindon Journal: BMC Musculoskelet Disord Date: 2010-10-10 Impact factor: 2.362
Authors: Janette Furuzawa-Carballeda; Guadalupe Lima; Luis Llorente; Carlos Nuñez-Álvarez; Blanca H Ruiz-Ordaz; Santiago Echevarría-Zuno; Virgilio Hernández-Cuevas Journal: ScientificWorldJournal Date: 2012-04-01
Authors: J Raúl Olmos-Zuñiga; Matilde Baltazares-Lipp; Claudia Hernández-Jiménez; Rogelio Jasso-Victoria; Miguel Gaxiola-Gaxiola; Mariana Silva-Martínez; Marco Antonio Iñiguez-García; A Ivan González-González; Juan Carlos Vázquez-Minero; Antonia Luna-Flores; Norma Solis-Alanis; Mario Enrique Baltazares-Lipp Journal: Biomed Res Int Date: 2020-08-27 Impact factor: 3.411
Authors: Silvia Méndez-Flores; Ángel Priego-Ranero; Daniel Azamar-Llamas; Héctor Olvera-Prado; Kenia Ilian Rivas-Redonda; Eric Ochoa-Hein; Andric Perez-Ortiz; Mario E Rendón-Macías; Estefano Rojas-Castañeda; Said Urbina-Terán; Luis Septién-Stute; Thierry Hernández-Gilsoul; Adrián Andrés Aguilar-Morgan; Dheni A Fernández-Camargo; Elizabeth Olivares-Martínez; Diego F Hernández-Ramírez; Gonzalo Torres-Villalobos; Janette Furuzawa-Carballeda Journal: Clin Transl Med Date: 2022-03